Litcius/Paper detail

Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19

J. Delaleu, Benjamin Deniau, Maxime Battistella, Adèle de Masson, Benoît Bensaïd, M. Jachiet, Ingrid Lazaridou, M. Bagot, Jean‐David Bouaziz, Gordon L. Archer, Amira Benattia, Anne Bergeron, Louise Bondeelle, Jean‐David Bouaziz, D. Bouda, David Boutboul, Berthon I. Brindel, Emmanuelle Bugnet, S. Caillat Zucman, S. Cassonnet, Karine Celli Lebras, Jacqueline Chabert, Sylvie Chevret, Meredith E. Clement, Claire Davoine, Nathalie De Castro, É. de Kerviler, Constance de Margerie‐Mellon, Constance Delaugerre, François Dépret, B. Denis, Lalia Djaghout, Clarisse Dupin, Dominique Farge, Catherine Fauvaux, E. Feredj, Delphine Feyeux, J.P. Fontaine, Véronique Frémeaux‐Bacchi, Lionel Galicier, Stéphanie Harel, Jegu AL, E. Kozakiewicz, Marc Lebel, Ariane Baye, J. Le Goff, Pierre Le Guen, E. Lengline, Geoffroy Liégeon, Gwenaël Lorillon, I. Madelaine Chambrin, G. Martin de Frémont, Marie Meunier, Jean‐Michel Molina, Florence Morin, Éric Oksenhendler, Régis Peffault de la Tour, Olivier Peyrony, Benoît Plaud, Maud Salmona, Julien Saussereau, Juliette Soret

2020The Journal of Allergy and Clinical Immunology In Practice30 citationsDOIOpen Access PDF

Topics & Concepts

HydroxychloroquineAcute generalized exanthematous pustulosisMedicineAdverse effectCoronavirus disease 2019 (COVID-19)DermatologyPandemicPneumoniaDrugCoronavirusIntensive care medicinePharmacologyInternal medicineInfectious disease (medical specialty)DiseaseDrug-Induced Adverse ReactionsBlood disorders and treatmentsCOVID-19 Clinical Research Studies